Risk Factors Associated with Ebola and Marburg Viruses Seroprevalence in Blood Donors in the Republic of Congo.

BACKGROUND:Ebola and Marburg viruses (family Filoviridae, genera Ebolavirus and Marburgvirus) cause haemorrhagic fevers in humans, often associated with high mortality rates. The presence of antibodies to Ebola virus (EBOV) and Marburg virus (MARV) has been reported in some African countries in indi...

Full description

Bibliographic Details
Main Authors: Nanikaly Moyen, Laurence Thirion, Petra Emmerich, Amelia Dzia-Lepfoundzou, Hervé Richet, Yannik Boehmann, Yannick Dimi, Pierre Gallian, Ernest A Gould, Stephan Günther, Xavier de Lamballerie
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS Neglected Tropical Diseases
Online Access:http://europepmc.org/articles/PMC4457487?pdf=render
_version_ 1828432199155712000
author Nanikaly Moyen
Laurence Thirion
Petra Emmerich
Amelia Dzia-Lepfoundzou
Hervé Richet
Yannik Boehmann
Yannick Dimi
Pierre Gallian
Ernest A Gould
Stephan Günther
Xavier de Lamballerie
author_facet Nanikaly Moyen
Laurence Thirion
Petra Emmerich
Amelia Dzia-Lepfoundzou
Hervé Richet
Yannik Boehmann
Yannick Dimi
Pierre Gallian
Ernest A Gould
Stephan Günther
Xavier de Lamballerie
author_sort Nanikaly Moyen
collection DOAJ
description BACKGROUND:Ebola and Marburg viruses (family Filoviridae, genera Ebolavirus and Marburgvirus) cause haemorrhagic fevers in humans, often associated with high mortality rates. The presence of antibodies to Ebola virus (EBOV) and Marburg virus (MARV) has been reported in some African countries in individuals without a history of haemorrhagic fever. In this study, we present a MARV and EBOV seroprevalence study conducted amongst blood donors in the Republic of Congo and the analysis of risk factors for contact with EBOV. METHODOLOGY AND FINDINGS:In 2011, we conducted a MARV and EBOV seroprevalence study amongst 809 blood donors recruited in rural (75; 9.3%) and urban (734; 90.7%) areas of the Republic of Congo. Serum titres of IgG antibodies to MARV and EBOV were assessed by indirect double-immunofluorescence microscopy. MARV seroprevalence was 0.5% (4 in 809) without any identified risk factors. Prevalence of IgG to EBOV was 2.5%, peaking at 4% in rural areas and in Pointe Noire. Independent risk factors identified by multivariate analysis were contact with bats and exposure to birds. CONCLUSIONS/SIGNIFICANCE:This MARV and EBOV serological survey performed in the Republic of Congo identifies a probable role for environmental determinants of exposure to EBOV. It highlights the requirement for extending our understanding of the ecological and epidemiological risk of bats (previously identified as a potential ecological reservoir) and birds as vectors of EBOV to humans, and characterising the protection potentially afforded by EBOV-specific antibodies as detected in blood donors.
first_indexed 2024-12-10T18:16:42Z
format Article
id doaj.art-bc5b0ff8b3f94d88bc946c9ae2efad41
institution Directory Open Access Journal
issn 1935-2727
1935-2735
language English
last_indexed 2024-12-10T18:16:42Z
publishDate 2015-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Neglected Tropical Diseases
spelling doaj.art-bc5b0ff8b3f94d88bc946c9ae2efad412022-12-22T01:38:19ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352015-01-0196e000383310.1371/journal.pntd.0003833Risk Factors Associated with Ebola and Marburg Viruses Seroprevalence in Blood Donors in the Republic of Congo.Nanikaly MoyenLaurence ThirionPetra EmmerichAmelia Dzia-LepfoundzouHervé RichetYannik BoehmannYannick DimiPierre GallianErnest A GouldStephan GüntherXavier de LamballerieBACKGROUND:Ebola and Marburg viruses (family Filoviridae, genera Ebolavirus and Marburgvirus) cause haemorrhagic fevers in humans, often associated with high mortality rates. The presence of antibodies to Ebola virus (EBOV) and Marburg virus (MARV) has been reported in some African countries in individuals without a history of haemorrhagic fever. In this study, we present a MARV and EBOV seroprevalence study conducted amongst blood donors in the Republic of Congo and the analysis of risk factors for contact with EBOV. METHODOLOGY AND FINDINGS:In 2011, we conducted a MARV and EBOV seroprevalence study amongst 809 blood donors recruited in rural (75; 9.3%) and urban (734; 90.7%) areas of the Republic of Congo. Serum titres of IgG antibodies to MARV and EBOV were assessed by indirect double-immunofluorescence microscopy. MARV seroprevalence was 0.5% (4 in 809) without any identified risk factors. Prevalence of IgG to EBOV was 2.5%, peaking at 4% in rural areas and in Pointe Noire. Independent risk factors identified by multivariate analysis were contact with bats and exposure to birds. CONCLUSIONS/SIGNIFICANCE:This MARV and EBOV serological survey performed in the Republic of Congo identifies a probable role for environmental determinants of exposure to EBOV. It highlights the requirement for extending our understanding of the ecological and epidemiological risk of bats (previously identified as a potential ecological reservoir) and birds as vectors of EBOV to humans, and characterising the protection potentially afforded by EBOV-specific antibodies as detected in blood donors.http://europepmc.org/articles/PMC4457487?pdf=render
spellingShingle Nanikaly Moyen
Laurence Thirion
Petra Emmerich
Amelia Dzia-Lepfoundzou
Hervé Richet
Yannik Boehmann
Yannick Dimi
Pierre Gallian
Ernest A Gould
Stephan Günther
Xavier de Lamballerie
Risk Factors Associated with Ebola and Marburg Viruses Seroprevalence in Blood Donors in the Republic of Congo.
PLoS Neglected Tropical Diseases
title Risk Factors Associated with Ebola and Marburg Viruses Seroprevalence in Blood Donors in the Republic of Congo.
title_full Risk Factors Associated with Ebola and Marburg Viruses Seroprevalence in Blood Donors in the Republic of Congo.
title_fullStr Risk Factors Associated with Ebola and Marburg Viruses Seroprevalence in Blood Donors in the Republic of Congo.
title_full_unstemmed Risk Factors Associated with Ebola and Marburg Viruses Seroprevalence in Blood Donors in the Republic of Congo.
title_short Risk Factors Associated with Ebola and Marburg Viruses Seroprevalence in Blood Donors in the Republic of Congo.
title_sort risk factors associated with ebola and marburg viruses seroprevalence in blood donors in the republic of congo
url http://europepmc.org/articles/PMC4457487?pdf=render
work_keys_str_mv AT nanikalymoyen riskfactorsassociatedwithebolaandmarburgvirusesseroprevalenceinblooddonorsintherepublicofcongo
AT laurencethirion riskfactorsassociatedwithebolaandmarburgvirusesseroprevalenceinblooddonorsintherepublicofcongo
AT petraemmerich riskfactorsassociatedwithebolaandmarburgvirusesseroprevalenceinblooddonorsintherepublicofcongo
AT ameliadzialepfoundzou riskfactorsassociatedwithebolaandmarburgvirusesseroprevalenceinblooddonorsintherepublicofcongo
AT herverichet riskfactorsassociatedwithebolaandmarburgvirusesseroprevalenceinblooddonorsintherepublicofcongo
AT yannikboehmann riskfactorsassociatedwithebolaandmarburgvirusesseroprevalenceinblooddonorsintherepublicofcongo
AT yannickdimi riskfactorsassociatedwithebolaandmarburgvirusesseroprevalenceinblooddonorsintherepublicofcongo
AT pierregallian riskfactorsassociatedwithebolaandmarburgvirusesseroprevalenceinblooddonorsintherepublicofcongo
AT ernestagould riskfactorsassociatedwithebolaandmarburgvirusesseroprevalenceinblooddonorsintherepublicofcongo
AT stephangunther riskfactorsassociatedwithebolaandmarburgvirusesseroprevalenceinblooddonorsintherepublicofcongo
AT xavierdelamballerie riskfactorsassociatedwithebolaandmarburgvirusesseroprevalenceinblooddonorsintherepublicofcongo